Biogen (BIIB) expects Q4 results to included a research milestone of USD 222mln; will impact adj. EPS by 1.26/shr
Importance
Level 1
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#BIOGEN IDEC INC#BIIB.US#FOREX#EQUITIES#METALS#EU SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#BIOGEN INC#BIIB#DXY#US EQUITIES